Cancer Clinical Investigation

Search results

• Center for Engineering and Precision Medicine [CEPM] Grand Opening

  Dordick, J., Vashishth,, D., Balchandani, P. & Friedman, S.

  30/03/23

  1 item of Media coverage

  Press/Media

• NYC Mayor Eric Adams Joined Top Biomedical Researchers To Usher In The Center For Engineering And Precision Medicine

  Dordick, J., Vashishth,, D. & Balchandani, P.

  30/03/23

  83 items of Media coverage

  Press/Media

• NYC Mayor Eric Adams Joined Top Biomedical Researchers To Usher In The Center For Engineering And Precision Medicine

  Dordick, J., Vashishth,, D. & Balchandani, P.

  30/03/23

  1 item of Media coverage

  Press/Media

• Studies from Icahn School of Medicine at Mount Sinai Provide New Data on Polycythemia Vera (Hepcidin Mimetics In Polycythemia Vera: Resolving the Irony of Iron Deficiency and Erythrocytosis)

  Hoffman, R., Ginzburg, Y. & Kremyanskaya, M.

  29/03/23

  1 item of Media coverage

  Press/Media

• NYC Mayor Eric Adams Joined Top Biomedical Researchers to Usher in the Center for Engineering and Precision Medicine at Hudson Research Center at 619 West 54th Street

  Dordick, J., Vashishth,, D. & Balchandani, P.

  29/03/23

  1 item of Media coverage

  Press/Media

• Caribou Biosciences Announces Dosing Of First Patient In The Cammouflage Phase 1 Trial Of CB-011, An Allogeneic Anti-BCMA CAR-T Cell Therapy For The Treatment Of Relapsed Or Refractory Multiple Myeloma

  Jagannath, S.

  29/03/23

  1 item of Media coverage

  Press/Media

• Investigators at Icahn School of Medicine at Mount Sinai Report Findings in Clinical Oncology (Targeted Degradation of Prc1 Components, Bmi1 and Ring1b, Via a Novel Protein Complex Degrader Strategy)

  Dale, B., Kabir, M. & Jin, J.

  27/03/23

  1 item of Media coverage

  Press/Media

• Findings from Icahn School of Medicine at Mount Sinai Yields New Findings on Non-Small Cell Lung Cancer (The Benefits and Harms of Adjuvant Chemotherapy for Non-small Cell Lung Cancer In Patients With Major Comorbidities: a Simulation Study)

  Veluswamy, R., Smith, C., Kale, M., Sigel, K., Leiter, A. & Kong, C. Y.

  22/03/23

  1 item of Media coverage

  Press/Media

• Sequencing T-cell redirection therapies leads to deep and durable responses in patients with relapsed/refractory myeloma

  Parekh, S.

  22/03/23

  1 item of Media coverage

  Press/Media

• New Findings in Multiple Myeloma Described from Icahn School of Medicine at Mount Sinai (Dissecting and Targeting Noncanonical Functions of Ezh2 In Multiple Myeloma Via an Ezh2 Degrader)

  Wang, J. & Jin, J.

  20/03/23

  1 item of Media coverage

  Press/Media

• Bispecific Antibodies Promise to be ‘Transformative’ in Multiple Myeloma

  Chari, A.

  17/03/23

  1 item of Media coverage

  Press/Media

• Data on Liver Cancer Detailed by Researchers at Icahn School of Medicine at Mount Sinai (Unannotated Small Rna Clusters Associated With Circulating Extracellular Vesicles Detect Early Stage Liver Cancer)

  Tabrizian, P., Sebra, R., Schwartz, M., Dogra, N., Villanueva Rodriguez, A., Hernandez Meza, G., Cordon-Cardo,, C., Allette, K., Garcia Lezana, T., Asgharpour, A., Llovet, J. & Dieterich, D.

  16/03/23

  1 item of Media coverage

  Press/Media

• Protagonist Therapeutics Announces Highly Statistically Significant Results from the Randomized Withdrawal Portion of the REVIVE Study of Rusfertide in Polycythemia Vera

  Hoffman, R.

  15/03/23

  85 items of Media coverage

  Press/Media

• Protagonist Therapeutics Announces Highly Statistically Significant Results from the Randomized Withdrawal Portion of the REVIVE Study of Rusfertide in Polycythemia Vera

  Hoffman, R.

  15/03/23

  1 item of Media coverage

  Press/Media

• FABA holding virtual workshop on drug discovery from March 13

  Reddy, E. P.

  11/03/23

  1 item of Media coverage

  Press/Media

• -BERGENBIO ANNOUNCES FIRST PATIENT DOSED IN PHASE 1B/2A TRIAL EVALUATING BEMCENTINIB IN 1ST LINE NON-SMALL CELL LUNG CANCER WITH STK11 MUTATIONS

  Veluswamy, R.

  10/03/23

  2 items of Media coverage

  Press/Media

• Australia Patent: Icahn School of Medicine at Mount Sinai Files Application for 'Compositions and methods for treating EZH2-mediated cancer'

  Jin, J.

  10/03/23

  1 item of Media coverage

  Press/Media

• Australia Patent: Application for 'Serine threonine kinase (AKT) degradation / disruption compounds and methods of use' Lapses

  Jin, J.

  10/03/23

  1 item of Media coverage

  Press/Media

• BerGenBio Announces First Patient Dosed in Phase 1b/2a Trial Evaluating Bemcentinib in 1st Line Non-Small Cell Lung Cancer with STK11 Mutations

  Veluswamy, R.

  9/03/23

  1 item of Media coverage

  Press/Media

• BerGenBio Announces First Patient Dosed in Phase 1b/2a Trial Evaluating Bemcentinib in 1st Line Non-Small Cell Lung Cancer with STK11 Mutations

  Veluswamy, R.

  9/03/23

  1 item of Media coverage

  Press/Media

• Bergenbio Announces First Patient Dosed In Phase 1B/2A Trial Evaluating Bemcentinib In 1St Line Non-Small Cell Lung Cancer With STK11 Mutations

  Veluswamy, R.

  9/03/23

  1 item of Media coverage

  Press/Media

• Protagonist Therapeutics: More Good News Likely To Come

  Ginzburg, Y.

  9/03/23

  1 item of Media coverage

  Press/Media

• CheckMate 274 follow up data boost nivolumab potential for high-risk bladder cancer

  Galsky, M.

  8/03/23

  1 item of Media coverage

  Press/Media

• Icahn School of Medicine at Mount Sinai Reports Findings in Depression (Stress-related reduction of hippocampal subfield volumes in major depressive disorder: A 7-Tesla study)

  Hof, P., Verma, G., Fleysher, L., Murrough, J., Balchandani, P., Brown, S. & Jacob, Y.

  7/03/23

  1 item of Media coverage

  Press/Media

• Researcher at Department of Radiation Oncology Describes Research in Head and Neck Cancer (Evaluation of Concomitant Systemic Treatment in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Radiotherapy)

  Bakst, R.

  7/03/23

  1 item of Media coverage

  Press/Media